We don’t just uncover all the teased stocks from those hyped-up newsletter ads we all see each day… we also keep track of those teased stocks, look for trends, and monitor performance, and the biggest story and the biggest driver of stock prices over the past year has been our newfound fascination with artificial intelligence. […]
Articles
- Most Relevant
- Most Recent
I’ve gotten quite a few questions about this spiel, which was for a recommendation that Mampilly was supposed to release yesterday (and presumably did) to his Extreme Fortunes subscribers, so I’m taking a look… despite the fact that I’m a little sick of writing about bitcoin. Extreme Fortunes is the “high end” newsletter Mampilly writes […]
Discussion Page for Aurinia Pharmaceuticals ($AUPH)This company was initially brought to my attention by Dr. KSS and Glenn Newby sometime back in 2015, as best as I can recall. It has been one of Dr. KSS’s most highly recommended stocks, though he always urged that you do your own DD. I have owned the stock since fairly early in the […]
Another Motley Fool growth stock to sniff out for you today … David Gardner has gotten a reputation as a compelling “rule breaking” growth stock picker over the past few decades, with some huge winners chosen (and held through very tumultuous times) as he built the Motley Fool with his brother Tom. The flagship Motley […]
Hey Travis, I received this in an email this morning and was wondering if you know the stock. Thanks! Craig Now, a promise like this would be preposterous coming from anyone else … however, when a person with Paul’s credentials comes forward, one is practically required to pay attention. After all, Paul’s $6 billion hedge […]
This article was originally published on January 3, though the ad had been running for some time before that. It continues to run now, and we get a lot of questions about it, so we’re re-posting our teaser solution here for your information. It has not been updated or revised since 1/3/24, the company has […]
This page is for discussion of Arch Therapeutics (ARTH).
[Ed. Note: Dr. KSS is an MD, PhD who writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, he choses his own topics, and his words and opinions are his own. Visit his Stock Gumshoe author page to see his past columns and most recent comments.] Readers have […]
“Upgrade” newsletter from Ian King, focuses on targeting 1,000% gains “on every single trade” in small cap stocks ($100 million to $3 billion) that are “disruptive.” Edited by Paul Mampilly until he left Banyan Hill in 2022.
No, Balthasar is not a biotech company. Think fast! Aragorn, Legolas and Gimli. Athos, Porthos and Aramis. Jaclyn, Farrah and Kate. Kirk, Spock and Bones. Barry, Robin and Maurice. Shadrach, Meshach and Abednego. History and culture bestow trios upon us because threesomes keep us rapt. The Three Magi, liking the Gummune as they do, have […]
Jeff Brown over at Bonner and Partners is launching a new newsletter called The Near Future Report, which sounds like it’s the “entry level” letter (currently offered at $75) to go with his pricier Exponential Tech Investor, and the first bait they’re dangling for new subscribers is a fat, juicy promise of a stock that […]
This teaser pitch from George Gilder has been filling up my inbox lately, but it’s also an older pitch that has for some reason been rejuvenated — this time, with a Donald Trump connection to help grab investors’ attention (when in doubt, throw the name of a polarizing politician into your teaser ad… it will […]
This article was originally published on December 1, 2020, but we’re seeing new versions with different headlines and that “March 2021” deadline, so we’re re-publishing our comments below. What follows has not been updated or revised in the past month. Lou Basenese is pitching Elon Musk’s next big idea in ads for his Trend Trader […]
We tend to get a lot of questions when there’s a new Paul Mampilly ad pounding the pavement, presumably because Banyan Hill tries so hard to reach pretty much everyone who has a pulse and an email address (with the latter being far more important than the former), so we’ll jump in on this Monday […]
This article was first published January 23, 2017, it has not been updated or revised. This ad caught my eye over the weekend, and it had enough clues that the Thinkolator started chugging along almost before I turned the switch this morning — so let’s dig in, and maybe we can even make it a […]
Yesterday we looked at one of the stocks Navellier has been pitching for his Ultimate Growth service, and today I’m moving on, as promised, to look at the second pick. And perhaps I should have swapped the order, since the ad actually called this one his “#1 Stock to Buy Today”… but, well, it seemed […]
Sometimes literary gimmicks backfire. In May 2015, we premiered “Cisco, Chang & Charlie” (sans Oxford comma) as a James Joycean brooding on the letter C, third letter of the alphabet, in three iterations. At the time, three stocks whose names begin with C were vying for attention and prompting questions from readers. The original plan […]
This is the first ticker specific discussion…..if it works, there may be many others. The aim is to have a chronological knowledge diary. If your comment is about ANYTHING other than $ARTH…please DONT post it here. **Please note that this post has been closed to further comment. The discussion on ARTH has moved over to […]
Rule Of 72 according to Investopedia: What is the ’Rule Of 72’ The rule of 72 is a shortcut to estimate the number of years required to double your money at a given annual rate of return. The rule states that you divide the rate, expressed as a percentage, into 72: Years required to double […]
[Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trade restrictions, chooses his own topics, and his words and opinions are his own. You can see all his past articles and more recent comments here.] Picture the gurbling fumaroles of Yellowstone: from the late 1990’s and on into […]
BIGGER THAN THE INTERNET? TEASER FROM REX MOORE TOUTING DAVID GARDNER’S UNCANNY ABILITY TO PICK WINNER’S…
Sometimes literary gimmicks backfire. In May 2015, we premiered “Cisco, Chang & Charlie” (sans Oxford comma) as a James Joycean brooding on the letter C, third letter of the alphabet, in three iterations. At the time, three stocks whose names begin with C were vying for attention and prompting questions from readers. The original plan […]
I would like to hear from some of the brave souls out there that invested in these two newsletters by Paul Mampilly. I subscribe to his flagship newsletter ”Profits Unlimited”, which I highly recommend to everyone, but have held out on the other two that are much pricier. Specifically, I would like to know his […]
Hi Gummies, I’ve had such a lovely time reading the many teases Travis has de-coded for us that I decided to give it a try myself. I received the following tease from Paul Mampilly today, with an invite to join his True Momentum program. I’m pretty sure that the company he plans to reveal on […]
Glenn Newberry in an earlier post today was asking whether Benlysta from GlaxoSmithKline (GSK), being trialled for lupus nephritis, poses any threat to Aurinia (AUPH). Benlysta is a monoclonal antibody that binds to and inhibits BAFF (B-cell activating factor). A company called Anthera (ANTH) is trialling blisibimod, an oral agent that does the same thing. […]
Hello all, I am looking to confirm the Agora Financial Breakthrough technology alert report, Augmented Reality MasterChip ticker symbol (Supercycle Iphone Killer) to be announced at september 22 Apple presser. Anyone else seeing this promo from Ray Blanco of AF toughting a ’masterChip’ manufacturer that will be in most augmented reality devices in the coming […]
I’ve gotten quite a few questions about this spiel, which was for a recommendation that Mampilly was supposed to release yesterday (and presumably did) to his Extreme Fortunes subscribers, so I’m taking a look… despite the fact that I’m a little sick of writing about bitcoin. Extreme Fortunes is the “high end” newsletter Mampilly writes […]
This article was originally published on January 12, 2017. I have updated my disclosures and the Irregulars Quick Take, and added some comments and number updates to update my thoughts on the stock, but many of the quotes are from the earlier version of the ad and not everything has been updated. The company being […]
Paul Mampilly is now promoting the new Bitcoin. Expects it to skyrocket 2325% next year. Will reveal the name September 5, at 9AM eastern time. Extreme Fortunes will be the Banyan publication. Now receive three reports from Mampilly and Banyan. Refuse to dish out another fortune in fees. Stuart
It’s time for the parade of “what’s in the next iPhone” pitches to begin, I suppose… And actually, we’re a little late — the prognosticating about the next Apple supplier to make you rich usually starts before this point, just a few weeks before the next product announcement, so perhaps that investing theme has lost […]
This article, originally titled “‘Universal Voice Control’ and ‘The End of Google as We Know it,’” was published on May 11. The ads have recently been coming in hot and heavy for this service, with the new ads headlined “Want to Invest like Jeff Bezos” and “Jeff Bezos’ Next Big Bet”, so we’re re-running this […]
Lou Basenese has a new service over at Agora called The Takeover Alert ($1,750), and he’s all but promising that he can identify takeover targets in advance… and give you the chance to make $29,000 profits from stocks that surge dramatically in just a day. To which the first response from any reader should be, […]
Just got the every day spam from Stansberry. ”1-tap app”, already has 700 million users, will rule the world… What is it? Thanks.
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can find his bio and his past articles on his Stock Gumshoe page.] “The universe (which others call the Library) is composed of an indefinite and […]
Jeff Brown over at Bonner and Partners is launching a new newsletter called The Near Future Report, which sounds like it’s the “entry level” letter (currently offered at $75) to go with his pricier Exponential Tech Investor, and the first bait they’re dangling for new subscribers is a fat, juicy promise of a stock that […]
Over time, I will try to collect past posts on these topics and collect them here. I’ll try to get the original posters and dates, although some are missing in this first post. JIN SHIN JYUTSU POSTS BY REBS (formerly Roger) Roger – At 87 I do Qigong, 8 brocades, Yang 10, 24, 48, 42, […]
That headline might look a little familiar to longtime Gumshoe readers… that’s because Michael Robinson had a very similar ad back in 2013 (and again in 2015) touting MEMS as a “device to end all disease” … … so, is the ad still about the same stock? Let’s look and see. Here’s how the pitch […]
$AMD, $STM, $NVDA, $SHOP all took a hit?
The purpose of this thread is to develop an energetic discussion of options trading that is particularly applicable to small biotech stocks as well as other similar small developing companies that have explosive potential. Concurrently I will provide a series of option trading instructional posts, commencing with the basics of options and proceeding through more […]
Average Investors Making Millions (See Their Secret) April 28, 2017April 28, 2017 J.L. Yastine The link is : https://banyanhill.com/exclusives/average-investors-making-millions-see-secret/?z=551020
Recent Comments
Certainly a risk, and it's interesting that FFH was one are that specifically cut -- despite calling it out as the most obviously appealing area for investment over the past…...
I have both Defiance and YieldMax funds, I can't wait to dump them due to the NAV erosion [I have added a GTC order on all my funds to the…...
He has had long "unbeaten" records in his core strategy, which sounds like it is essentially just selling covered calls. That probably leads to stable returns, though I don't know…...
So I looked at the ingredients of the Celsius drinks and discovered the marketing BS, "natural flavors." It does not take the interested person long to discover (and most everyone…...
For sure. When I heard that he was starting a new venture concentrating on an under-represented sector of the market, I thought finally someone was going to get serious about…...
And is his guide to how to handle the old PBRG investments useful?...
Thanks for the Info.!!...
There is a new blood test, Galleri I think that’s it, that can detect most cancers via a methylation pathway. All cancers do this. Also Function Heath for $499 a…...
I like Teeka no matter the debacle at Legacy Research. I do look forward to his explanation but it won't change the fact that Teeka is really good at what…...
Sorry folks; I seem to be confusing TSM, STM and SMT. And, while at it miss-spelled "dubious". The "under the radar stock" that Weiss recommended is STM, not SMT, which…...
Correction! Pardon my dyslexia; Yesterday I wrote that Weiss was recommending STM as an "under the radar" stock, chiding them for characterizing "the world's biggest chip maker" as such. I…...
Great teaching and value. Opened up world of options that has become a major part of my investment strategy....
Pfizer - you can check the investment amount/stake of each of those Billionares. The only issue I saw is that Pfizer only had 7 FDA approvals last year, but that…...
Here is Stansberry Research's track record on ASLE: While ASLE went from 22 to 6 and I am down -$64K, FTAI went from 6 to 72, was never recommended by…...
Did you receive the Infinity "update" over the weekend? More cut and paste and pseudo quant talk. Nothing about miners or the original Infinity hypothesis. So far no updates on…...
I started a thread here on those two TSLY and NVDY. They have paid well but NVDY has more importantly held up and appreciated while TSLY has not. Active management…...
Not really. A month is just a month, and seasonality is not so critical for the southern half of the country, which is where DFH operates. Could become a concern,…...
When I saw that a while back that Ms. Woods was heavy in RXRX and the NVDA investment I picked up a few hundred shares under $6.500 around Thanksgiving 2023…...
I certainly get your point of view and feel the same. I still like to keep my options open so I plan to watch the presentation. If he has Burke…...
RXRX they bought shares of as part of a collaboration a year ago, the other holdings are much older -- Nano-X is a remnant of a venture investment that NVDA…...
Did we ever find out the names of the cryptos from Altucher...
Yep, I remember those stories -- that got a little traction after Fukushima again, as I recall (as an investment narrative, not as an actual business), but faded fast....
Hi Travis. Thank you for your relentless dedication to keep us informed and educated. I have a lifetime subscription to Weiss Ratings' "Disruptors & Dominators" . Below are the recommendations…...
At that point from a technology perspective the most valuable company will be Intel which has made the investment with ASML to take the lead. Intel's 20A and 18A processes…...
I've noted several comments in this forum which outline rather well the would be investment counselor reality and wanted to share my point of view for what its worth. I…...
Regarding your statement, "other senses dial up in intensity": I doubt that it's a matter of your other senses becoming "more sensitive." Instead, what you have probably done is simply…...
Yes, Tilson's #1 investment, the "would feel safe putting half my kids inheritance in" is still Berkshire Hathaway (he used to say, "kids college fund," but his kids are I…...
No one has weighed in on this post since 8/23. The war in Ukraine is still going on, and there is no end in sight. Whitney Tilson is back on…...
I used to value Fry's investment recommendations, but have not had a good run with his current portfolio. Out of 47 tickers in his portfolio, 21 are down and it…...
these are all good companies and viable investments that pay dividends to shareholders. that is the bedrock of sensible investing. please explain how that constitutes a scam...
these investments pay you year in and year out like clockwork. but if you're not smart enough to see that, lottery tickets probably are your best bet...
"I decided they’d had enough time to prove that they could build and compound per-share value, and had largely failed to do so" Doc - This business has "compounded" from…...
Dear Travis, I used to be in the "Gumshoe" business myself with very limited success. I'm glad I found for no other reason(s) than the time savings, the mountains of…...
I have owned Wheaton since early 2009 and have seen my shares rise from $4.11 (Canadian funds) to over $70. WPM is the best long-term streaming investment available today. They…...
I was in BWXT at $73 just prior to you October piece. See my comment there for my view then. Short answer is that this is the ONLY company with…...
Travis, you've reminded me of an old friend of mine and consummate investor who tried to buy Google on the day of its IPO. He wasn't successful then, but picked…...
What is a MILF in terms of a stock investment?...
These are strictly income focused etfs with a strong likelihood of NAV erosion. One must be very selective with these etfs; They are not for investors seeking total returns. However,…...
Ycharts tries to simulate the impact of dividend reinvestment, but I'm sure it's not perfect -- there may be a little compounding impact that doesn't show. Not much compounding to…...
I'm retired now and use REITs and MLPs to generate income. Every day Mr Market makes you an offer. I don't care about his schizo yo-yo behavior. When I look…...
Well apparently investorsplace is offering us any of their paid subscriptions as an exchange so to speak but none of our PB investments are really being talked about . Which…...
The paper that she looked at was retracted. Here is what the editors of the journal wrote: "Following publication, concerns were raised regarding a number of claims made in this…...
Actually, India's fatality rate is just below that of the US. No, India did not distribute ivermectin. You are probably referring to one state that supposedly did so....
Stansberry Research was teasing a $7 gold trade 3 years ago that they predicted would make all kinds of money, then went to a $6 gold trade in their promotions,…...
Could be, there will definitely be some big losers in that portfolio, particularly among the stocks that I bought in 2021 (though the most recent one is also doing poorly,…...
It appears that Mr. King has made this same pitch, with slightly changed wording, for the past two or three years. Checking back, expert crypto sleuths have come up empty…...
This is the strategy. Buy puts out of the money. Lose most of your investment. Enjoy " the sky is falling" newsletters and bizarre conspiracies...
I listened to it and it seemed a bit out there. I don't see panic and i can't figure out the investment premise here....
I just watched the Altshuler pitch. It is the company that Ray Blanco, Jim Rickards and Altshuler believe will go to 100x investment. This company is dependent on th x…...
WoW fantastic post Travis. Kudos Greatly appreciate esp the a January 2023-to-date chart for each. And NVIDIA is powering ahead almost the Apple for the new age of Intelligence .…...